Einstein-Rockefeller-CUNY Center for AIDS Research

Developmental Core

The overarching goal of the Einstein/Rockefeller/Hunter CFAR (ERC-CFAR) Developmental Core is to support the career development of early stage investigators (ESIs) through an effective mentoring process coupled with a peer-reviewed Catalytic grants program and ongoing support for their scientific growth via participation in programs specifically tailored for ESIs. The objectives of the ERC-CFAR Developmental core are centered on mentoring ESIs, catalyzing trans-institutional collaborative AIDS research in the ERC-CFAR, supporting Scientific Working Group (SWG) efforts to catalyze research in their topic areas, facilitating scientific communication among ERC-CFAR investigators and enhancing international HIV/AIDS research. Specifically the Core:

  • Provides individually tailored mentoring to ESIs and facilitates their development into independently funded researchers by pairing ESIs with established investigators (EIs), by providing both individual and group-level mentoring to help them develop NIH K- or R- type grants and by assisting senior level ESIs with transition to an R01 funding.
  • Supports ESIs engaged in AIDS research in the ERC-CFAR via catalytic and micro grants, which will also be used to promote trans- institutional collaborations and to support SWG priorities.
  • Stimulates intra- and trans-institutional, collaborative AIDS research at the participating institutions by awarding joint catalytic grants and proactively recruits non-AIDS EIs engaged in cutting edge research into AIDS research.
  • Facilitates scientific communication among ERC-CFAR investigators by organizing a bi-weekly Trans-institutional ERC-CFAR research seminar series and the biweekly Clinical AIDS Grand Rounds series both of which are simulcast to all three institutions, ERC-CFAR Invited Speaker Seminars, Annual ERC-CFAR Scientific Retreats to foster scientific interaction.
  • Promotes AIDS Research in the ERC-CFAR via integration with other Einstein programs such as WIHS, the AIDS T32 program and African HIV/AIDS research programs.
  • Facilitates and mentors ESIs in conducting community participatory and behavioral AIDS research via collaboration with the Behavioral Science Core.
  • For further information or to access the Developmental Core services, please contact Drs. Prasad or Cunningham. 

Dr. Vinayaka Prasad
Director, ERC-CFAR Developmental Core
Director, HIV/AIDS Training Grant
Professor, Microbiology & Immunology, Einstein  

Dr. Chinazo Cunningham
Co-Director, ERC-CFAR Developmental Core
Professor, Medicine and of Family & Social Medicine 
Director, Diversity Affairs for the Dept. of Medicine
Associate Chief, Division of General Internal Medicine, Einstein


Einstein Logo 

Rockefeller Logo 

CUNY Logo 


ERC-CFAR at a Glance

Partner Institutions 

  • Albert Einstein College of Medicine
  • Rockefeller University
  • The City University of New York (CUNY)


Total ERC-CFAR members

  • 183 Full members
  • 10 Affiliate members

CFAR member trainees funded by NIH K awards

  • 15 Full members

NIH Funding 

FY2015 OAR NIH AIDS FRB grants

$34,084,840 Total costs


New NIH AIDS grants awarded in FY2016

$7,345,645 Total annual costs


FY2014 non-AIDS NIH grants

$34,745,334 Total costs

Publications (first 6 months of 2016) 

Total Publications: 240

Publications multi-authored
by ERC-CFAR members: 91



Director: Dr. H. Goldstein



Directors: Dr. V. Prasad & Dr. C. Cunningham


Biomarkers & Advanced Technologies 

Directors: Dr. J. Berman & Dr. S. Almo


Behavioral Science 

Director: Dr. L. Bauman


Clinical Translational Implementation Science 

Director: Dr. K. Anastos


Scientific Working Groups 

HIV and Eradication 

Directors: Dr. G. Kalpana & Dr. M. Caskey


Patient and Population Health Outcomes Research 

Directors: Dr. D. Nash & Dr. J. Arnsten  

New 2016 NIH Grants Awards 

Click here to log in

In the Media

Can an Immune Strategy Used to Treat Cancer Also Wipe Out HIV Infections?

Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.

(Thursday, Aug 08, 2019)

Trump's HIV Plan Met With Both Cautious Optimism, Flat-Out Skepticism

Harris Goldstein, M.D., says he is encouraged by the prospect of increased federal funds for regional AIDS research centers that help advance treatments and improve health outcomes. Dr. Goldstein is director of the Einstein-Rockefeller-CUNY Center for AIDS Research and an attending physician at Children’s Hospital at Montefiore.

(Tuesday, Feb 12, 2019)

coverage on other stories